Precigen Inc (PGEN)
1.40
+0.07
(+5.26%)
USD |
NASDAQ |
May 31, 16:00
1.405
0.00 (0.00%)
After-Hours: 20:00
Precigen Enterprise Value: 308.63M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 308.63M |
| May 30, 2024 | 290.96M |
| May 29, 2024 | 283.39M |
| May 28, 2024 | 299.79M |
| May 24, 2024 | 298.53M |
| May 23, 2024 | 293.48M |
| May 22, 2024 | 303.58M |
| May 21, 2024 | 306.11M |
| May 20, 2024 | 306.11M |
| May 17, 2024 | 303.58M |
| May 16, 2024 | 308.63M |
| May 15, 2024 | 318.73M |
| May 14, 2024 | 301.06M |
| May 13, 2024 | 296.01M |
| May 10, 2024 | 275.82M |
| May 09, 2024 | 280.86M |
| May 08, 2024 | 290.96M |
| May 07, 2024 | 303.58M |
| May 06, 2024 | 318.73M |
| May 03, 2024 | 313.68M |
| May 02, 2024 | 308.63M |
| May 01, 2024 | 308.63M |
| April 30, 2024 | 288.44M |
| April 29, 2024 | 308.63M |
| April 26, 2024 | 311.15M |
| Date | Value |
|---|---|
| April 25, 2024 | 305.59M |
| April 24, 2024 | 310.60M |
| April 23, 2024 | 305.59M |
| April 22, 2024 | 300.59M |
| April 19, 2024 | 288.07M |
| April 18, 2024 | 285.57M |
| April 17, 2024 | 283.07M |
| April 16, 2024 | 295.58M |
| April 15, 2024 | 305.59M |
| April 12, 2024 | 310.60M |
| April 11, 2024 | 318.10M |
| April 10, 2024 | 308.09M |
| April 09, 2024 | 308.09M |
| April 08, 2024 | 308.09M |
| April 05, 2024 | 305.59M |
| April 04, 2024 | 295.58M |
| April 03, 2024 | 305.59M |
| April 02, 2024 | 303.09M |
| April 01, 2024 | 313.10M |
| March 31, 2024 | 318.10M |
| March 28, 2024 | 298.08M |
| March 27, 2024 | 298.08M |
| March 26, 2024 | 285.63M |
| March 25, 2024 | 286.88M |
| March 22, 2024 | 284.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
147.81M
Minimum
Nov 13 2023
2.127B
Maximum
Jan 04 2021
759.15M
Average
637.49M
Median
Enterprise Value Benchmarks
| Cyclacel Pharmaceuticals Inc | 1.036M |
| HealthEquity Inc | 7.508B |
| Corvus Pharmaceuticals Inc | 112.98M |
| Oragenics Inc | 8.699M |
| MAIA Biotechnology Inc | 95.45M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.74M |
| Revenue (Quarterly) | 1.065M |
| Total Expenses (Quarterly) | 25.48M |
| EPS Diluted (Quarterly) | -0.10 |
| Gross Profit Margin (Quarterly) | -0.94% |
| Profit Margin (Quarterly) | -2.23K% |
| Earnings Yield | -27.86% |
| Normalized Earnings Yield | -24.78 |